Beacon Investment Advisory Services Inc. Sells 1,895 Shares of Intuitive Surgical, Inc. $ISRG

Beacon Investment Advisory Services Inc. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 36,626 shares of the medical equipment provider’s stock after selling 1,895 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Intuitive Surgical were worth $14,565,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Newbridge Financial Services Group Inc. grew its holdings in Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Main Street Group LTD acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $31,000. Vermillion Wealth Management Inc. increased its position in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 25 shares in the last quarter. Finally, Turning Point Benefit Group Inc. raised its stake in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Activity

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. The trade was a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 6,634 shares of company stock valued at $2,796,795. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent research reports. Raymond James Financial restated an “outperform” rating and set a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Sanford C. Bernstein reduced their price target on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. JPMorgan Chase & Co. decreased their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $487.00 price objective (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. Twenty equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $509.02.

Intuitive Surgical Price Performance

ISRG opened at $378.81 on Friday. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The company has a market capitalization of $133.83 billion, a price-to-earnings ratio of 43.39, a P/E/G ratio of 2.70 and a beta of 1.46. The firm’s fifty day moving average price is $392.87 and its two-hundred day moving average price is $445.78.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the company posted $1.81 earnings per share. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.